Health & Medicine
Pfizer acquires Metsera in $4.9B deal amid biotech boom
Pfizer will pay $4.9 billion to acquire Metsera, a company whose shares debuted at just $18, after its lead obesity candidate showed 11.3% weight loss in early trials, according to Biospace . This mul
Maria Flores·June 29, 2026
